NTLA : Intellia Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-10-31 |
|---|---|---|---|---|
| 2025 | $12.81 | $12.81 | $12.81 | 1.5% |
| 2026 | $13.66 | $13.04 | $13.95 | 8.21% |
| 2027 | $14.49 | $13.98 | $14.95 | 14.79% |
| 2028 | $14.82 | $14.78 | $14.87 | 17.47% |
| 2029 | $14.78 | $14.77 | $14.81 | 17.15% |
| 2030 | $14.89 | $14.81 | $15.01 | 18.01% |
| 2031 | $15.23 | $15.04 | $15.38 | 20.69% |
| 2032 | $15.46 | $15.39 | $15.58 | 22.49% |
| 2033 | $15.08 | $14.61 | $15.52 | 19.48% |
| 2034 | $14.07 | $13.08 | $14.56 | 11.49% |
| 2035 | $11.55 | $10.21 | $12.78 | -8.47% |
The 24 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of
$30.19 with a high forecast of $68.0 and a low forecast of $10.0.
The average Intellia Therapeutics stock forecast represents a 139.22%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast for 2025, 1 predictions are offered for each month of 2025 with average Intellia Therapeutics stock
forecast of $12.81, a high forecast of $12.81, and a low forecast of $12.81.
The average Intellia Therapeutics stock forecast 2025 represents a 1.5%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Intellia Therapeutics stock
forecast of $13.66, a high forecast of $13.95, and a low forecast of $13.04.
The average Intellia Therapeutics stock forecast 2026 represents a 8.21%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Intellia Therapeutics stock
forecast of $14.82, a high forecast of $14.87, and a low forecast of $14.78.
The average Intellia Therapeutics stock forecast 2028 represents a 17.47%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock
forecast of $14.89, a high forecast of $15.01, and a low forecast of $14.81.
The average Intellia Therapeutics stock forecast 2030 represents a 18.01%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast 2031, 12 predictions are offered for each month of 2031 with average Intellia Therapeutics stock
forecast of $15.23, a high forecast of $15.38, and a low forecast of $15.04.
The average Intellia Therapeutics stock forecast 2031 represents a 20.69%
increase from the last price of $12.619999885559082.
For Intellia Therapeutics stock forecast for 2035 (10 year), 11 predictions are offered for each month of 2035 with average Intellia Therapeutics stock
forecast of $11.55, a high forecast of $12.78, and a low forecast of $10.21.
The average Intellia Therapeutics stock forecast 2035 represents a -8.47%
decrease from the last price of $12.619999885559082.
Please, see more forecasts below.
NTLA : Intellia Therapeutics stock forecast by Wall Street Analysts
The average Intellia Therapeutics stock forecast from last 6 month is $30.19, and this show a -18.07% decrease in average from the prior price target of the each prediction. Also, this average forecast of $30.19 represents a -30.47% decrease from the past average forecast of $43.42, 6 months ago from 19 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-30 | HC Wainwright & Co. | $25.00 | $18.0000 | Buy |
| 2025-10-28 | Bernstein | $14.0000 | $14.5000 | Market Perform |
| 2025-10-28 | RBC Capital | $21.00 | $14.0000 | Sector Perform |
| 2025-10-28 | Barclays | $26.00 | $24.0000 | Overweight |
| 2025-10-28 | JMP Securities | $33.0000 | $29.0000 | Market Outperform |
| 2025-10-28 | Wells Fargo | $45.00 | $17.0000 | Equal-Weight |
| 2025-10-27 | Chardan Capital | $60.00 | $48 | Buy |
| 2025-10-27 | HC Wainwright & Co. | $30.0000 | $25.0000 | Buy |
| 2025-10-27 | B of A Securities | $36.0000 | $30.0000 | Buy |
| 2025-10-06 | JMP Securities | $33.0000 | Market Outperform | |
| 2025-09-19 | HC Wainwright & Co. | $25.0000 | $30.0000 | Buy |
| 2025-09-19 | JMP Securities | Market Perform | ||
| 2025-08-13 | Guggenheim | $45.00 | $14.0000 | Buy |
| 2025-08-11 | Chardan Capital | $68.0000 | $60 | Buy |
| 2025-08-08 | HC Wainwright & Co. | $30.00 | $25.0000 | Buy |
| 2025-08-08 | Wells Fargo | $50.0000 | $45.0000 | Overweight |
| 2025-08-08 | RBC Capital | $25.0000 | $21.0000 | Outperform |
| 2025-06-16 | HC Wainwright & Co. | $30.0000 | $30.0000 | Buy |
| 2025-06-03 | Canaccord Genuity | $74.0000 | $54.0000 | Buy |
| 2025-05-29 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-20 | HC Wainwright & Co. | $30.0000 | $30 | Buy |
| 2025-05-19 | Wedbush | $10.0000 | $10.0000 | Neutral |
| 2025-05-12 | Guggenheim | $55.0000 | $45.0000 | Buy |
| 2025-05-09 | Chardan Capital | $68.00 | $68.00 | Buy |
| 2025-05-09 | Citigroup | $14.00 | $10.0000 | Neutral |
| 2025-04-21 | Wolfe Research | $21.0000 | Outperform | |
| 2025-03-05 | HC Wainwright & Co. | $30 | Buy | |
| 2025-03-04 | Truist Securities | $90.0000 | $50 | Buy |
| 2025-02-28 | Barclays | $55.00 | $26.0000 | Overweight |
| 2025-02-28 | Citigroup | $12.0000 | $14.0000 | Neutral |
| 2025-02-28 | Wells Fargo | $60.00 | $50.0000 | Overweight |
| 2025-02-28 | Chardan Capital | $91.00 | $68.0000 | Buy |
| 2025-02-28 | JP Morgan | $45.0000 | $13.0000 | Neutral |
| 2025-01-27 | Morgan Stanley | $56.0000 | $11.0000 | Equal-Weight |
| 2025-01-14 | Goldman Sachs | $19.0000 | $12 | Neutral |
| 2025-01-13 | Oppenheimer | $60.00 | $40 | Outperform |
| 2025-01-10 | BMO Capital | $70.00 | $50 | Outperform |
| 2025-01-10 | Wells Fargo | $70.00 | $60.0000 | Overweight |
| 2024-11-19 | Canaccord Genuity | $90.0000 | $90.0000 | Buy |
| 2024-11-18 | Chardan Capital | $88.0000 | $91.0000 | Buy |
| 2024-11-18 | Wedbush | $14.0000 | $14 | Neutral |
| 2024-11-18 | Wells Fargo | $80.0000 | $70.0000 | Overweight |
| 2024-11-11 | Oppenheimer | $70.00 | $60 | Outperform |
| 2024-11-08 | Barclays | $76.0000 | $55.0000 | Overweight |
Intellia Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-11-03 | $13.70 | 8.59% |
| 2025-11-04 | $14.00 | 2.19% |
| 2025-11-05 | $14.33 | 2.37% |
| 2025-11-06 | $14.41 | 0.52% |
| 2025-11-07 | $14.22 | -1.33% |
NTLA : Long term Intellia Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Dec. is $12.81 , for 2026 Nov. is $13.94 , for 2029 Nov. is $14.80 , for 2030 Nov. is $14.98 , for 2034 Nov. is $13.39 , and for 2035 Nov. is $10.21.
NTLA : Intellia Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Dec. | $12.81 | 1.50% |
NTLA : Intellia Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $13.04 | 1.78% |
| 2026 Feb. | $13.25 | 1.63% |
| 2026 Mar. | $13.40 | 1.11% |
| 2026 Apr. | $13.51 | 0.86% |
| 2026 May. | $13.62 | 0.77% |
| 2026 Jun. | $13.70 | 0.65% |
| 2026 Jul. | $13.79 | 0.60% |
| 2026 Aug. | $13.85 | 0.43% |
| 2026 Sep. | $13.89 | 0.32% |
| 2026 Oct. | $13.94 | 0.34% |
| 2026 Nov. | $13.94 | 0.04% |
| 2026 Dec. | $13.95 | 0.03% |
NTLA : Intellia Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $13.98 | 0.24% |
| 2027 Feb. | $14.05 | 0.48% |
| 2027 Mar. | $14.16 | 0.78% |
| 2027 Apr. | $14.27 | 0.83% |
| 2027 May. | $14.38 | 0.75% |
| 2027 Jun. | $14.45 | 0.47% |
| 2027 Jul. | $14.51 | 0.42% |
| 2027 Aug. | $14.61 | 0.73% |
| 2027 Sep. | $14.73 | 0.80% |
| 2027 Oct. | $14.83 | 0.66% |
| 2027 Nov. | $14.91 | 0.57% |
| 2027 Dec. | $14.95 | 0.26% |
NTLA : Intellia Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $14.87 | -0.56% |
| 2028 Feb. | $14.83 | -0.25% |
| 2028 Mar. | $14.87 | 0.24% |
| 2028 Apr. | $14.87 | 0.02% |
| 2028 May. | $14.85 | -0.12% |
| 2028 Jun. | $14.83 | -0.13% |
| 2028 Jul. | $14.82 | -0.07% |
| 2028 Aug. | $14.81 | -0.09% |
| 2028 Sep. | $14.80 | -0.08% |
| 2028 Oct. | $14.79 | -0.05% |
| 2028 Nov. | $14.78 | -0.04% |
| 2028 Dec. | $14.78 | -0.02% |
NTLA : Intellia Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $14.78 | -0.00% |
| 2029 Feb. | $14.78 | -0.00% |
| 2029 Mar. | $14.78 | -0.00% |
| 2029 Apr. | $14.78 | -0.02% |
| 2029 May. | $14.77 | -0.01% |
| 2029 Jun. | $14.78 | 0.02% |
| 2029 Jul. | $14.78 | 0.02% |
| 2029 Aug. | $14.78 | 0.02% |
| 2029 Sep. | $14.79 | 0.03% |
| 2029 Oct. | $14.79 | 0.03% |
| 2029 Nov. | $14.80 | 0.04% |
| 2029 Dec. | $14.81 | 0.05% |
NTLA : Intellia Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $14.81 | 0.05% |
| 2030 Feb. | $14.82 | 0.06% |
| 2030 Mar. | $14.83 | 0.07% |
| 2030 Apr. | $14.84 | 0.08% |
| 2030 May. | $14.86 | 0.09% |
| 2030 Jun. | $14.87 | 0.10% |
| 2030 Jul. | $14.89 | 0.11% |
| 2030 Aug. | $14.91 | 0.13% |
| 2030 Sep. | $14.93 | 0.14% |
| 2030 Oct. | $14.95 | 0.16% |
| 2030 Nov. | $14.98 | 0.18% |
| 2030 Dec. | $15.01 | 0.20% |
NTLA : Intellia Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $15.04 | 0.22% |
| 2031 Feb. | $15.08 | 0.23% |
| 2031 Mar. | $15.11 | 0.25% |
| 2031 Apr. | $15.15 | 0.25% |
| 2031 May. | $15.19 | 0.26% |
| 2031 Jun. | $15.23 | 0.25% |
| 2031 Jul. | $15.26 | 0.23% |
| 2031 Aug. | $15.30 | 0.21% |
| 2031 Sep. | $15.32 | 0.18% |
| 2031 Oct. | $15.35 | 0.15% |
| 2031 Nov. | $15.37 | 0.13% |
| 2031 Dec. | $15.38 | 0.10% |
NTLA : Intellia Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $15.39 | 0.07% |
| 2032 Feb. | $15.40 | 0.05% |
| 2032 Mar. | $15.41 | 0.04% |
| 2032 Apr. | $15.41 | 0.02% |
| 2032 May. | $15.41 | 0.01% |
| 2032 Jun. | $15.41 | 0.00% |
| 2032 Jul. | $15.42 | 0.03% |
| 2032 Aug. | $15.44 | 0.19% |
| 2032 Sep. | $15.52 | 0.51% |
| 2032 Oct. | $15.58 | 0.33% |
| 2032 Nov. | $15.56 | -0.07% |
| 2032 Dec. | $15.54 | -0.12% |
NTLA : Intellia Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $15.52 | -0.16% |
| 2033 Feb. | $15.48 | -0.26% |
| 2033 Mar. | $15.42 | -0.39% |
| 2033 Apr. | $15.34 | -0.53% |
| 2033 May. | $15.24 | -0.64% |
| 2033 Jun. | $15.13 | -0.71% |
| 2033 Jul. | $15.02 | -0.71% |
| 2033 Aug. | $14.92 | -0.68% |
| 2033 Sep. | $14.83 | -0.62% |
| 2033 Oct. | $14.75 | -0.55% |
| 2033 Nov. | $14.68 | -0.49% |
| 2033 Dec. | $14.61 | -0.43% |
NTLA : Intellia Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $14.56 | -0.38% |
| 2034 Feb. | $14.51 | -0.36% |
| 2034 Mar. | $14.45 | -0.38% |
| 2034 Apr. | $14.39 | -0.41% |
| 2034 May. | $14.33 | -0.45% |
| 2034 Jun. | $14.26 | -0.47% |
| 2034 Jul. | $14.19 | -0.52% |
| 2034 Aug. | $14.09 | -0.67% |
| 2034 Sep. | $13.93 | -1.15% |
| 2034 Oct. | $13.68 | -1.77% |
| 2034 Nov. | $13.39 | -2.16% |
| 2034 Dec. | $13.08 | -2.31% |
NTLA : Intellia Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $12.78 | -2.27% |
| 2035 Feb. | $12.51 | -2.12% |
| 2035 Mar. | $12.26 | -1.96% |
| 2035 Apr. | $12.04 | -1.85% |
| 2035 May. | $11.82 | -1.82% |
| 2035 Jun. | $11.60 | -1.86% |
| 2035 Jul. | $11.37 | -1.99% |
| 2035 Aug. | $11.12 | -2.21% |
| 2035 Sep. | $10.84 | -2.50% |
| 2035 Oct. | $10.53 | -2.82% |
| 2035 Nov. | $10.21 | -3.10% |
Financial Data for Intellia Therapeutics stock
Frequently Asked Questions about Intellia Therapeutics stock forecast
Is Intellia Therapeutics a good long term stock?
From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2025 Dec. is $12.80983063537712 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2026 Nov. is $13.942782425852396 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2029 Nov. is $14.799291900641078 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2030 Nov. is $14.978702612202682 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock can be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2034 Nov. is $13.385904399269116 From Intellia Therapeutics stock forecast , Intellia Therapeutics (NTLA) stock cannot be a good investment choice. According to AIPickup, the Intellia Therapeutics stock price forecast for 2035 Nov. is $10.20621595319745
Is Intellia Therapeutics stock overvalued?
Intellia Therapeutics (NTLA) stock is expected to go UP . Therefore, AIPickup would say that Intellia Therapeutics (NTLA) stock is NOT overvalued.
Will Intellia Therapeutics stock price go up?
Yes. The Intellia Therapeutics stock price forecast for 2026 Nov. is $13.942782425852396
Is Intellia Therapeutics stock a good buy now?
Since closing price on 2025-10-31 is $12.619999885559082 and forecast for 2026 Nov. is $13.94, Intellia Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Intellia Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| NTLA stock price for 2025-10-14 | $23.90 | $23.10 | $21.89 | $24.83 |
| NTLA stock price for 2025-10-15 | $25.93 | $24.48 | $24.23 | $26.32 |
| NTLA stock price for 2025-10-16 | $24.91 | $25.93 | $24.65 | $26.82 |
| NTLA stock price for 2025-10-17 | $24.75 | $24.31 | $23.99 | $25.18 |
| NTLA stock price for 2025-10-20 | $27.98 | $25.56 | $25.50 | $28.25 |
| NTLA stock price for 2025-10-21 | $26.97 | $27.60 | $26.70 | $27.86 |
| NTLA stock price for 2025-10-22 | $24.58 | $26.69 | $24.14 | $26.90 |
| NTLA stock price for 2025-10-23 | $25.89 | $24.59 | $24.27 | $25.95 |
| NTLA stock price for 2025-10-24 | $25.60 | $26.11 | $25.31 | $26.35 |
| NTLA stock price for 2025-10-27 | $14.79 | $13.73 | $13.21 | $16.76 |
| NTLA stock price for 2025-10-28 | $13.96 | $14.77 | $13.72 | $14.79 |
| NTLA stock price for 2025-10-29 | $13.12 | $13.77 | $12.62 | $14.00 |
| NTLA stock price for 2025-10-30 | $12.27 | $11.78 | $11.63 | $12.70 |
| NTLA stock price for 2025-10-31 | $12.62 | $12.55 | $12.13 | $13.38 |